Apyx Medical Corporation Appoints Stavros Vizirgianakis as Executive Chairman and Grants RSUs

Apyx Medical Corporation has entered into a material definitive agreement with Stavros Vizirgianakis, the Chairman of its Board of Directors, appointing him as Executive Chairman. In this role, Mr. Vizirgianakis will provide strategic leadership, governance oversight, assist management with corporate initiatives, support investor engagement, and advise on capital markets and corporate development. He will not be considered an officer or employee of the company. To recognize his service, the Board approved a grant of 450,000 restricted stock units (RSUs) under the Company's 2023 Share Incentive Plan. These RSUs will vest over a period of two years, with 150,000 vesting immediately, and the remainder vesting in monthly installments over the subsequent 12 and 24 months, subject to his continued service. The agreement also details provisions for vesting acceleration upon a change of control and outlines responsibilities regarding taxes and compliance with applicable laws.